Galectin-3 and ST-2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip) - Research portal of Justus Liebig University Giessen:

Meeting Abstract

Galectin-3 and ST-2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip)

Authors list: Doerr, O.; Walther, C.; Liebetrau, C.; Sommer, T.; Lorenz, J.; Moellmann, H.; Gaede, L.; Boeder, N. F.; Weipert, K.; Troidl, C.; Voss, S.; Bauer, T.; Hamm, C.; Nef, H. M.

Publication year: 2017

Pages: 268-268

Journal: European Heart Journal

Volume number: 38

ISSN: 0195-668X

eISSN: 1522-9645

Publisher: Oxford University Press

Authors/Editors

- Dr. med. Jakob Ferdinand Lorenz

Citation Styles

Harvard Citation style: Doerr, O., Walther, C., Liebetrau, C., Sommer, T., Lorenz, J., Moellmann, H., et al. (2017) Galectin-3 and ST-2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip), European Heart Journal, 38, p. 268

APA Citation style: Doerr, O., Walther, C., Liebetrau, C., Sommer, T., Lorenz, J., Moellmann, H., Gaede, L., Boeder, N., Weipert, K., Troidl, C., Voss, S., Bauer, T., Hamm, C., & Nef, H. (2017). Galectin-3 and ST-2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip). European Heart Journal. 38, 268.